These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35726606)

  • 1. Metabolic syndrome following a first episode of psychosis: results of a 1-year longitudinal study conducted in metropolitan Lisbon, Portugal.
    Coentre R; Levy P; Góis C; Figueira ML
    J Int Med Res; 2022 Jun; 50(6):3000605221106703. PubMed ID: 35726606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort.
    Garrido-Torres N; Ruiz-Veguilla M; Olivé Mas J; Rodríguez Gangoso A; Canal-Rivero M; Juncal-Ruiz M; Gómez-Revuelta M; Ayesa-Arriola R; Crespo-Facorro B; Vázquez-Bourgon J
    Span J Psychiatry Ment Health; 2023; 16(3):175-183. PubMed ID: 38520081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: Baseline results from the PAFIP cohort.
    Garrido-Torres N; Ruiz-Veguilla M; Alameda L; Canal-Rivero M; Ruiz MJ; Gómez-Revuelta M; Ayesa-Arriola R; Rubio-García A; Crespo-Facorro B; Vázquez-Bourgon J
    Schizophr Res; 2022 Aug; 246():277-285. PubMed ID: 35878542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis use and metabolic syndrome among clients with first episode psychosis.
    Stiles E; Alcover KC; Stiles B; Oluwoye O; McDonell MG
    Early Interv Psychiatry; 2021 Aug; 15(4):1051-1055. PubMed ID: 32881419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-grade inflammation in first-episode psychosis is determined by increased waist circumference.
    Keinänen J; Suvisaari J; Reinikainen J; Kieseppä T; Lindgren M; Mäntylä T; Rikandi E; Sundvall J; Torniainen-Holm M; Mantere O
    Psychiatry Res; 2018 Dec; 270():547-553. PubMed ID: 30343240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial.
    Storch Jakobsen A; Speyer H; Nørgaard HCB; Hjorthøj C; Krogh J; Mors O; Nordentoft M
    Schizophr Res; 2018 Sep; 199():96-102. PubMed ID: 29501386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between smoking, components of metabolic syndrome and lipoprotein particle size.
    Slagter SN; van Vliet-Ostaptchouk JV; Vonk JM; Boezen HM; Dullaart RP; Kobold AC; Feskens EJ; van Beek AP; van der Klauw MM; Wolffenbuttel BH
    BMC Med; 2013 Sep; 11():195. PubMed ID: 24228807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for metabolic syndrome in individuals with recent-onset psychosis at disease onset and after 1-year follow-up.
    Alonso Y; Miralles C; Algora MJ; Valiente-Pallejà A; Sánchez-Gistau V; Muntané G; Labad J; Vilella E; Martorell L
    Sci Rep; 2022 Jul; 12(1):11386. PubMed ID: 35794221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased high-density lipoprotein cholesterol and insulin resistance were the most common criteria in 12- to 19-year-old adolescents.
    Budak N; Oztürk A; Mazicioglu M; Yazici C; Bayram F; Kurtoglu S
    Eur J Nutr; 2010 Jun; 49(4):219-25. PubMed ID: 19876664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran.
    Delavari A; Forouzanfar MH; Alikhani S; Sharifian A; Kelishadi R
    Diabetes Care; 2009 Jun; 32(6):1092-7. PubMed ID: 19279302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early insulin resistance predicts weight gain and waist circumference increase in first-episode psychosis--A one year follow-up study.
    Keinänen J; Mantere O; Kieseppä T; Mäntylä T; Torniainen M; Lindgren M; Sundvall J; Suvisaari J
    Schizophr Res; 2015 Dec; 169(1-3):458-463. PubMed ID: 26589392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-ups of metabolic, inflammatory and oxidative stress markers, and brachial-ankle pulse wave velocity in middle-aged subjects without metabolic syndrome.
    Kim OY; Paik JK; Lee JY; Lee SH; Lee JH
    Clin Exp Hypertens; 2013; 35(5):382-8. PubMed ID: 23148723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis.
    Nettis MA; Pergola G; Kolliakou A; O'Connor J; Bonaccorso S; David A; Gaughran F; Di Forti M; Murray RM; Marques TR; Blasi G; Bertolino A; Pariante CM; Dazzan P; Mondelli V
    Psychoneuroendocrinology; 2019 Jan; 99():145-153. PubMed ID: 30243054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression is a risk factor for metabolic syndrome: Results from the ELSA-Brasil cohort study.
    Ferriani LO; Silva DA; Molina MDCB; Mill JG; Brunoni AR; da Fonseca MJM; Moreno AB; Benseñor IM; de Aguiar OB; Barreto SM; Viana MC
    J Psychiatr Res; 2023 Feb; 158():56-62. PubMed ID: 36571912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of metabolic syndrome in female and male patients at risk of psychosis.
    Cordes J; Bechdolf A; Engelke C; Kahl KG; Balijepalli C; Lösch C; Klosterkötter J; Wagner M; Maier W; Heinz A; de Millas W; Gaebel W; Winterer G; Janssen B; Schmidt-Kraepelin C; Schneider F; Lambert M; Juckel G; Wobrock T; Riedel M; Moebus S
    Schizophr Res; 2017 Mar; 181():38-42. PubMed ID: 27751654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reported organic food consumption and metabolic syndrome in older adults: cross-sectional and longitudinal analyses.
    Aljahdali AA; Baylin A; Ludwig-Borycz EF; Guyer HM
    Eur J Nutr; 2022 Apr; 61(3):1255-1271. PubMed ID: 34750641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and gallstone disease.
    Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
    World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study).
    Akinmolayemi O; Saldanha S; Joshi PH; Deodhar S; Ayers CR; Neeland IJ; Rohatgi A
    PLoS One; 2021; 16(9):e0257574. PubMed ID: 34547056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere length as a marker of cellular aging is associated with prevalence and progression of metabolic syndrome.
    Révész D; Milaneschi Y; Verhoeven JE; Penninx BW
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4607-15. PubMed ID: 25188715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low HDL levels as the most common metabolic syndrome risk factor in heart failure.
    Karadag MK; Akbulut M
    Int Heart J; 2009 Sep; 50(5):571-80. PubMed ID: 19809206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.